rs58212659

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_021098.3(CACNA1H):​c.2145C>T​(p.Ser715Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000479 in 1,612,336 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0020 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.11

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 16-1204152-C-T is Benign according to our data. Variant chr16-1204152-C-T is described in ClinVar as Benign. ClinVar VariationId is 529684.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.11 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00202 (308/152356) while in subpopulation AFR AF = 0.00695 (289/41584). AF 95% confidence interval is 0.00629. There are 2 homozygotes in GnomAd4. There are 149 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 308 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.2106C>T p.Ser702Ser synonymous_variant Exon 10 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.2106C>T p.Ser702Ser synonymous_variant Exon 10 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2145C>T p.Ser715Ser synonymous_variant Exon 10 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*58C>T non_coding_transcript_exon_variant Exon 10 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*1592C>T non_coding_transcript_exon_variant Exon 9 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2145C>T non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*58C>T 3_prime_UTR_variant Exon 10 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*1592C>T 3_prime_UTR_variant Exon 9 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.00202
AC:
307
AN:
152238
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00695
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000719
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000587
AC:
144
AN:
245276
AF XY:
0.000529
show subpopulations
Gnomad AFR exome
AF:
0.00742
Gnomad AMR exome
AF:
0.000407
Gnomad ASJ exome
AF:
0.00141
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000452
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000318
AC:
464
AN:
1459980
Hom.:
0
Cov.:
32
AF XY:
0.000285
AC XY:
207
AN XY:
726264
show subpopulations
African (AFR)
AF:
0.00899
AC:
301
AN:
33474
American (AMR)
AF:
0.000470
AC:
21
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.000919
AC:
24
AN:
26120
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39684
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86230
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52016
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000747
AC:
83
AN:
1111690
Other (OTH)
AF:
0.000481
AC:
29
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00202
AC:
308
AN:
152356
Hom.:
2
Cov.:
33
AF XY:
0.00200
AC XY:
149
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00695
AC:
289
AN:
41584
American (AMR)
AF:
0.000718
AC:
11
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68034
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00123
Hom.:
0
Bravo
AF:
0.00246
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.81
DANN
Benign
0.92
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58212659; hg19: chr16-1254152; API